The Recall Desk
Agency classClass IIOur severity:SevereFDA (Drugs)·D-0714-2017·Announced 2017-05-24

Key Pharmacy Recalls DMPS Acid Injections Due to Sterility Concerns

Key Pharmacy and Compounding Center is recalling 214 vials of DMPS Acid injections because the firm cannot assure the sterility of the product.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, FDA Class II recalls involving significant injury/property-damage reports or hospitalization are rated as Severe (4). While specific injury reports are not detailed in the text, the agency classification and the nature of the sterility defect in a sterile injection place it in this category.

Plain-English summary

Key Pharmacy and Compounding Center is recalling 214 vials of DMPS Acid 50mg/ml injections. The product is a prescription-only sterile compounded drug prepared in 5 mL glass single-dose vials.

The recall was initiated due to a lack of assurance of sterility. The firm is recalling these sterile compounded drugs while they are within their expiration dates to address this quality concern.

The affected vials were distributed nationwide in the U.S.A., as well as in Australia and Canada. Consumers and healthcare providers should stop using the recalled product and contact their pharmacist or the recalling firm for further instructions.

The recalled product

Product
DMPS ACID *5ML* SDV 50MG/ML INJ, Injection, 50mg/ml, Rx only, 5 mL glass/ Single Dose vial, Prepared by Key Compounding Pharmacy
Manufacturer
Key Pharmacy and Compounding Center
Category
Drug — Compounded Sterile Drug
Hazard
Affected units
214

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (18)

  • Lot # t12-16-2016@73
  • Exp 4/18/2017
  • t12-27-2016@93
  • Exp 4/27/2017
  • t01-09-2017@102
  • Exp 5/10/2017
  • t01-10-2017@120
  • Exp 5/11/2017
  • 02-01-2017@78
  • Exp 6/1/2017
  • t02-08-2017@96
  • Exp 6/9/2017
  • t02-20-2017@80
  • Exp 6/21/2017
  • t02-21-2017@122
  • Exp 6/23/2017
  • t02-23-2017@68
  • Exp 6/24/2017.

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 79 recalled by Key Pharmacy and Compounding Center under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 79 products in this recall →

Related recalls

Same manufacturer · Key Pharmacy and Compounding Center

See all →

Same hazard · sterility failure

See all →

Similar recalls